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Abstract
Structural biology and structural genomics projects routinely rely on recombinantly expressed proteins, but many proteins
and complexes are difficult to obtain by this approach. We investigated native source proteins for high-throughput protein
crystallography applications. The Escherichia coli proteome was fractionated, purified, crystallized, and structurally
characterized. Macro-scale fermentation and fractionation were used to subdivide the soluble proteome into 408 unique
fractions of which 295 fractions yielded crystals in microfluidic crystallization chips. Of the 295 crystals, 152 were selected for
optimization, diffraction screening, and data collection. Twenty-three structures were determined, four of which were novel.
This study demonstrates the utility of native source proteins for high-throughput crystallography.
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Introduction
Since the advent of recombinant DNA technology, structural
and biochemical research has focused increasingly on the
characterization of recombinantly expressed prokaryotic and
eukaryotic proteins. However, statistics from the National
Institutes of Health Protein Structure Initiative (PSI) (http://
targetdb.pdb.org/statistics/TargetStatistics.html) indicate that of
successfully clones and expressed proteins, less than 5% of the
targets selected result in a crystal structure. Protein production,
purification, and crystallization remain a series of bottlenecks for
large scale structural studies of any given genome [1]. These
results suggest that new approaches are warranted in order to
access the great majority of proteins and protein complexes that
cannot be facilely recombinantly expressed for structural and
biochemical analysis.
To fill this gap, we investigated the feasibility of native-source
protein purification as part of a high-throughput crystallization
and structure determination pipeline. The methodologies de-
scribed provide a complementary approach to current structural
genomics initiatives. By providing an alternative to recombinant
technology for protein production, the native source purification
and crystallization pipeline outlined here can potentially expand
the scope of structural studies to proteins that currently cannot be
obtained or are difficult to obtain by recombinant DNA
techniques due to low levels of expression, poor solubility, the
lack of necessary post-translational modifications, or instability due
to missing partners in the native protein complex. Based on these
experiments, we demonstrate successful structural characterization
of multiple proteins using only microgram quantities of purified
material. By scaling up the amount of starting material and
introducing atypical methods of filtration and fractionation, we
obtained sufficient quantities of 408 unique samples for crystal-
lization trials. Simultaneously, scaling down the amount of protein
sample used for crystallization, enabled structure determination of
protein species from native sources.
Results
Escherichia coli was chosen as a model system in this study due to
its relatively small and structurally well-studied proteome and
fully-sequenced genome [2,3]. Of the ,4243 predicted ORFs in
the E. coli proteome, over a quarter are likely to encode membrane
associated or membrane bound proteins. This study focused on
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e32498the soluble portion of the proteome. In a typical experiment, large-
scale fermentation (120 L) was used to provide sufficient starting
material for downstream purification and crystallization. To
maximize access to soluble proteins, we grew the cells aerobically
to log phase at 37uC in minimal media. Large scale fermentation
allowed the production of kilogram quantities of cells, while
minimizing the deleterious effect of high cell density on protein
quality. Automated fermentation was necessary to monitor the
growth conditions, maintain appropriate aeration, control pH, and
to produce enough starting material for downstream crystallization
experiments [4].
Purification of proteins from a native source presented very
different challenges compared to recombinantly overexpressed
and affinity tagged proteins. To successfully purify unique protein
samples from the native proteome, a series of orthogonal steps
were used (Figure 1). Initial fractionation steps relied on rapid
tangential flow methods and pilot-scale ion exchange chromatog-
raphy using new high-capacity resins to process large amounts of
E. coli lysate (0.5–1 kg cells). Based on size predictions of all
predicted ORFs present in E. coli, a large peak at approximately
20 kDa was expected from initial profiling of the proteome
(Figure 2A). The soluble proteins, however, had large peaks at void
volume (over 500 kDa) and approximately 100 kDa (Figure 2B),
suggesting that many proteins were either aggregated or forming
large multimeric complexes. In order to separate these two peaks,
an initial step of tangential flow filtration was used to allow the
rapid generation of a rough cut between a high molecular weight
fraction (over 500 kDa), and a lower molecular weight fraction.
While the higher molecular weight fraction likely contained
aggregates, organelles, and soluble protein complexes, this fraction
was not extensively pursued. Further fractionation using sucrose
gradients was attempted; however no crystals were obtained from
the high molecular weight fraction leading us to focus on the
fraction under 500 kDa.
The ,500 kDa fraction was further purified through a series of
orthogonal steps including the first ion exchange step on pilot-scale
columns with step elution at salt concentrations ranging from 0.01
to 1 M. Ion exchange allowed the selection of different pools of
proteins based on the isoelectric point (pI) and enabled initial
proteome simplification to create reproducible and manageable
subsets of proteins. The proteome subsets were subjected to a
series of downstream purifications including affinity purification,
hydrophobic interaction chromatography, gel exclusion, and high-
resolution ion exchange chromatography. Final fraction purity
ranged from approximately 95% to less than 5%, with the
majority of fractions comprising at least 30% of one protein species
(Figure 2C). By fractionating the soluble portion of the proteome
and retaining all fractions for further subdivision in sequential
steps, the number of unique samples for downstream crystalliza-
tion was maximized from a single preparation of bacterial cells. In
addition, as the number of fractions increased exponentially
during purification, fractions were frozen to facilitate handling and
processing. By retaining all fractions during purification, the
number of fractions processed to final purity could be easily scaled
depending on available time and personnel. The large scale
production and purification of proteins from the soluble E. coli
proteome constituted a macro scale step in the crystallization
pipeline. To our knowledge, this represents the first use of pilot
systems for whole-proteome fractionation and subsequent crystal-
lization. The proteins produced from this step were then subjected
to microscale characterization and crystallization using micro-
fluidic technology.
To maximize the number of protein crystal structures solved,
the crystallization platform needed to effectively use the small
amounts of available samples from native purification. Micro-
fluidic crystallization allowed routine sampling of 96 conditions
with as little as 10 mg of protein [5,6,7]. Scaling up protein
production and purification yielded enough material for thousands
of individual crystallization trials, even for samples present in
relatively low abundance (less than 100 ug of purified protein).
Thus, even a small amount of sample was sufficient in many cases
to screen and optimize crystals for X-ray structure determination
at a synchrotron source.
The proteome fractionation step in the pipeline yielded 408
unique fractions, as identified by capillary electrophoresis,
containing one or more proteins (Figure 3A). All these fractions
were used in crystallization trials in microfluidic chips. Surpris-
ingly, sample complexity did not correlate with crystallization hits
or crystal quality (Figure 3B and C). We obtained crystals in 295 of
the 408 fractions, representing 73% of the total fractions obtained.
Out of these, we focused on 152 of the higher quality crystals,
where crystal quality was scored based on size and morphology.
Of the fractions that were selected for crystal optimization and
data collection, 37 unique datasets were collected at synchrotron
beamlines, with a maximum resolution ranging from 1.8 A ˚ to 7 A ˚.
Twenty eight of the 37 datasets had a resolution better than 3.5 A ˚.
Protein identification was done after successful crystallization
and x-ray data collection. Due to limited available sample and the
high complexity of many of the crystallized fractions, mass
spectrometry was only successful in identifying approximately
20% of the crystallized proteins. Brute force molecular replace-
ment trials were used to identify proteins in the majority of the
crystallized and well diffracting samples. In ,80% of the cases
tested here, where the resolution was 3.5 A ˚ or better, this strategy
Figure 1. Proteome fractionation and purification flow chart.
Approximately 500 g of E. coli cells were lysed at pH 7 using a
microfluidizer and the cell debris pelleted. The supernatant was applied
to a tangential flow column with a nominal molecular weight cut off of
500 kDa, generating 2 fractions (retentate and flow through). The
fraction above 500 kDa (retentate) was further purified via sucrose
gradients, size exclusion, and ion exchange chromatography prior to
crystallization trials. The fraction less than 500 kDa was applied to
multiple affinity and ion exchange columns followed by phenyl
sepharose, ion exchange, and size exclusion prior to crystallization
trials in microfluidic chips.
doi:10.1371/journal.pone.0032498.g001
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structure (Table 1). Brute-force molecular replacement trials were
conducted using 10,747 structures in the PDB with at least 30%
sequence identity to an E. coli ORF. Each data set collected was
screened against all search models using the program MOLREP
[8]. Rotation function Z-scores were calculated and an arbitrary
cut-off between 6 to 7 was used to determine whether a potentially
correct solution had been found prior to a full translational search
using MOLREP and/or PHASER [9]. For all structures solved,
visual inspection of the electron density map was sufficient to
unambiguously determine whether or not the solution was correct.
Only novel structures not present in the PDB were further refined.
In all, we determined 23 structures (Figure 4 and Table 1), four
of them not deposited in the protein data bank. These novel
structures represent enzymes involved in stress response, specifi-
cally methylglyoxal reductase (YghZ) (Table 2 and Figure 5), as
well as three enzymes important in core metabolic functions,
phosphoglucose isomerase (pGI) (Table 3 and Figure 6), 6-
phospho-beta-glucosidase (BglA) (Table 4 and Figure 7), and
glutamate dehydrogenase (GDH) (Table 5 and Figure 8). All the
proteins are oligomeric (YghZ, pGI, BglA, GDH) and belong to
Figure 2. E. coli proteome predicted and experimental charac-
terization. (A) Predicted size distribution of all ORFs in the E. coli
proteome. (B) Size exclusion chromatograph of crude E. coli lysate with
the largest peak at approximately 100 kDa. (C) Final step ion exchange
(MonoQ) purification in a typical fractionation experiment. Peaks
marked with a star were sent for downstream crystallization trials.
doi:10.1371/journal.pone.0032498.g002
Figure 3. Crystallization of native source E. coli proteins. (A)
Capillary electrophoresis of purified protein fractions. White stars
indicate samples successfully crystallized and black stars represent
solved structures. (B) Crystals of 5-keto-4-deoxyuronate isomerase
crystallized from fractions of varying purity. Crystal quality was not
always correlated with sample purity. (C) Resolution of the data
collected versus percent purity of the starting sample based on
quantification of protein concentrations by capillary gel electrophoresis
with the Caliper system. Sample purity did not correlate with higher
resolution data.
doi:10.1371/journal.pone.0032498.g003
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barrel structure, pGI adopts an alpha/beta fold, and GDH
possesses a core Rossmann fold found in many nucleotide binding
proteins. The percent identity of these four novel structures
compared to deposited structures ranged from 33% (YghZ) to
65% (pGI).
Methylglyoxal reductase (YghZ)
The aldo-ketoreductases, of which YghZ is a member, are a large
family of NADPH-dependent oxidoreductases that have the
function of reducing various aldehydes and ketones [10]. The
YghZ enzyme likely functions as a methylglyoxal reductase and is
known to convert thetoxic metabolite methylglyoxalto acetolin vitro
and in vivo. As inthe largerfamilyof aldo-keto reductases, YghZ,has
a central TIM barrel domain and a smaller, mostly helical domain.
YghZ isa distanthomolog (,40%sequenceidentity)of mammalian
aflatoxin dialdehyde reductases of the aldo-keto reductase AKR7
family and to potassium channel b-subunits in the AKR6 family
[11,12], the structure of which was used for molecular replacement.
The structure of YghZ reveals the protein forms a stable tetramer
based on structural homology to relatedproteins in the PDB (3ERP)
and the amount of buried surface area of the tetramer interface [13]
(Figure 5). Based on sequence alignments and structural alignments
with other aldo-keto reductases, likely catalytic residues were
Table 1. Crystallization conditions and data collection statistics for previously deposited structures.
PDB ID Resolution this study Resolution PDB Rsym I/sigI R-free Crystallization conditions Protein description
1IPW 3.2 2.3 0.179 3.6 0.41 15–20% PEG 1000,
100 mM MES pH 6.0,
300–400 mM KOAc
Inorganic pyrophosphatase
1XRU 3.0 1.94 0.065 10.1 0.31 1.5 M Ammonium
sulfate, 0.1 M MES, pH 6.5
5-keto-4-deoxyuronate isomerase
1N57 2.8 1.6 0.122 15.5 0.27 0.1 M MgCl2, 0.1 M Tris
pH 8.5, 20% PEG 10,000,
0.5% ethyl acetate
Hsp31
1R2K 2.0 2.1 0.054 17.4 0.29 1.4 M sodium citrate
tribasic dihydrate,
0.1 M Hepes, pH 7.5
MoaB (molybdopterin biosynthesis
protein B)
1BJN 2.2 2.3 0.052 20.0 0.29 0.2 M MgCl2, 0.1 M HEPES
pH 7.5, 15% PEG 3350
phosphoserine aminotransferase
1GG9 2.5 1.89 0.126 7.2 0.28 200 mM NaCl, 100 mM Tris
pH 8.5, 20% PEG 3350
Catalase HPII
1PKY 3.2 2.5 0.08 20.5 0.34 0.05 M Ammonium sulfate,
0.05 M Bis-Tris, pH 6.5, 30%
pentaerythritol ethoxylate
Pyruvate kinase I
1CS1 3.25 1.5 0.109 5.7 0.36 45% polypropylene glycol
400, 0.1 M Bis-Tris, pH 6.5
Cystathione gamma-synthase
1TJ7 3.0 2.44 0.166 21.6 0.29 0.1 M Bis-Tris pH 6.5, 1.6 to
0.8 M Ammonium sulfate.
Ariginosuccinate lyase
1BBW 3.4 2.7 0.142 9.4 0.35 0.1 M Tris pH 8.5, 25% PEG
3350, 3% isopropanol
Lysyl-tRNA synthetase (constitutive)
1NXG 3.3 2.5 0.077 8.4 0.32 0.2 M Lithium sulfate
monohydrate, 25% PEG
3350, 0.1 M Tris, pH 8.5
Citrate synthase
1DHP 3.0 2.3 0.182 5.6 0.29 0.1 M HEPES pH 7.5,
10–25% PEG 3350
Dihydrodipicolinate synthase
1YAC 2.3 1.8 0.106 6.8 0.25 0.1 M Bis-Tris pH 6.5, 45%
Polypropylene glycol P 400
ycaC gene product
1612 4.0 2.0 0.129 5.3 0.42 0.2 M NaFormate, 20%
PEG 3350, 3% MeOH
Nicotinamide nucleotide
transhydrogenase domain I
1YE9 2.5 2.8 0.174 11.4 0.33 0.1 M MgFormate,
18% PEG 3350
Catalase HPII (truncated)
1HOT 2.2 2.4 0.134 16 0.34 0.056 M sodium phosphate
monobasic monohydrate,
1.344 M potassium
phosphate dibasic, pH 8.2
Glucosamine 6-phosphate
deaminase
1CG1 2.7 2.5 0.051 26.6 0.35 0.1 M TRIS pH 8.5, 25% PEG
3350
Adenylosuccinate synthetase
2PWZ 1.6 2.2 0.07 27 0.42 1.1 M Sodium malonate
in 0.1 M HEPES pH 7,
0.5% Jeffamine ED-2001
Malate dehydrogenase
1PMO 2.0 2.3 0.087 11.9 0.32 0.2 M Ammonium citrate
tribasic pH 7, 20% PEG3350
Glutamate decarboxylase
doi:10.1371/journal.pone.0032498.t001
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and Asp-61) form a putative catalytic tetrad in the active site.
Although some extra electron density was noted in the active site,
the density was too diffuse to reliably model the dinucleotide
cofactor or substrate/product molecules.
Glucose-6-phosphate isomerase (pGI)
Glucose-6-phosphate isomerase (pGI) catalyzes the reversible
isomerization of D-glucose-6-phosphate to D-fructose-6-phosphate
in glycolysis and gluconeogenesis, and facilitates the recycling of
hexose-6-phosphate in the pentose phosphate pathway [14,15].
The protein has an alpha/beta fold with an extensive dimer
interface. The active site, identified based on sequence and
structural alignments with related proteins, is formed at the dimer
interface and comprises residues Arg270, Glu355 and His386,
with the active site histidine donated from the partner monomer
(Figure 6). The catalytic mechanism is an acid-base type
mechanism with Glu355 acting as a putative general base,
abstracting a proton from the substrate to facilitate the reversible
isomerization of the substrate molecule. Histidine 386 donates a
proton, facilitating the ring opening mechanism. As expected from
the high sequence identity (over 60% identical), the E. coli pGI
dimer aligns extremely well with the mammalian enzyme
structures used for molecular replacement [15].
6-phospho-beta-glucosidase (BglA)
6-phospho-beta-glucosidase (BglA), is a cytoplasmic enzyme and
part of the glycosal hydrolase family that is able to hydrolyse
aromatic b-glucoside phosphates into glucose-6-phosphate and a
hydroxyl aromatic in vitro. E. coli has several predicted enzymes in
this family, whose physiological role has not been fully described.
BglA forms an 8-strand alpha/beta TIM barrel with the putative
catalytic residues Glu180 and Glu377 located in beta strands 4
and 7. Additional density was noted in the active site and a sulfate
molecule from the crystallization conditions was well ordered
adjacent to the putative catalytic residues Glu180 and Glu377 and
formed hydrogen bonding interactions with Thr434 and Trp425.
Modeling glucose-6-phosphate into the active site based on the
position of the sulfate molecule revealed residues likely involved in
substrate positioning (Figure 7).
Glutamate dehydrogenase
Glutamate dehydrogenase (GDH), catalyzes the reversible
oxidative deamination of glutamate to a-ketoglutarate and
ammonia, using either NAD
+ or NADP
+ as a cofactor. The
reverse reaction generates glutamate and the reduced cofactor
NADH or NADPH, thus GDH has a pivotal role between carbon
and nitrogen metabolism, particularly in plants and bacteria. The
majority of characterized glutamate dehydrogenases are homo-
Figure 4. Structures of previously deposited proteins solved during the pipeline. All proteins were oligomers as shown above. Proteins are
from top left - inorganic pyrophosphatase (1IPW), 5-keto-4-deoxyuronate isomerase (1XRU), Hsp31 (1N57), pyruvate kinase (1PKY), phosphoserine
aminotransferase (1BJN), Citrate synthase (1NXG), ycaC gene product (1YAC), Cystathione gamma-synthase (1CS1), Dihydrodipicolinate synthase
(1DHP), Arginosuccinate lyase (1TJ7), Nicotinamide nucleotide transhydrogenase domain I (1612), MoaB (molybdopterin biosynthesis protein B)
(1R2K), Catalase HPII (1GG9), Lysyl-tRNA synthetase (constitutive) (1BBW), Glutamate decarboxylase (1PMO), Glucosamine 6-phosphate deaminase
(IHOT), Malate dehydrogenase (2PWZ), Adenylosuccinate synthetase (1CG1), catalase HPII truncated (1YE9).
doi:10.1371/journal.pone.0032498.g004
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being the most frequent [16]. GDH from E. coli crystallized as a
hexamer, consistent with biochemical observations [17], and
contains two domains – a larger C-terminal Rossmann fold
containing domain and a second N-terminal helical capping
domain (Figure 8). The putative active site is located in a cleft
between the two domains.
Discussion
Current estimates suggest that E. coli cells produce over 1100
cytosolic soluble proteins that vary in abundance up to 5 logs [18].
Many of these proteins are expected to form macromolecular
complexes, reducing the number of molecular species to less than
1000 [19,20]. Our aim was to fractionate the crude lysate in
several distinct ways in order to obtain as many of these species as
possible in relatively pure fractions. Using a ‘‘macro-to-micro’’
approach that combined macro scale methods for the production
and purification of native source proteins with novel microfluidic
methods for protein sample analysis and crystallization, we were
able to expand previous work that focused on proteome
fractionation alone and to develop a robust structure determina-
tion pipeline using native source proteins.
Previous studies have shown that the soluble proteins of the E.
coli proteome can be fractionated using ion exchange chromatog-
raphy and unique proteins identified by mass spectrometry from 2-
D gel spots [21]. Based on these studies that successfully simplified
and fractionated the soluble portion of the proteome, we were able
to scale-up these purification steps in order to obtain enough
material for downstream crystallization experiments. The powerful
combination of multiple chromatographic methods (tangential
flow fractionation, ion exchange chromatography on high capacity
resins, size exclusion chromatography, pH shifts, affinity chroma-
tography, and limited proteolysis) to subdivide the E. coli proteome
allowed the generation of unique protein samples for downstream
crystallization and structure determination.
While in many cases lower purity samples may require further
purification steps in order to be suitable for downstream
crystallization experiments, it was observed that some proteins
present in as little as 5% abundance still crystallized and yielded
crystals of sufficient quality for structure determination (Figure 3 B
and C). Thus, in contrast to the classical biochemistry approach
where the final objective is to achieve a highly pure sample by
removing trace impurities prior to crystallization, we found that
many well diffracting crystals could be obtained from fairly
complex samples. This successful crystallization from complex
samples is most probably due to the inherent propensity of certain
proteins to crystallize and will not be true in all cases. As this study
sampled a broad swathe of the E. coli proteome, our results are
likely biased towards proteins with a high degree of crystal-
lizability.
Size-exclusion chromatographic characterization of the lower
molecular weight protein fraction (less than 500 kDa) showed a
maximum peak at approximately 100 kDa, while analysis of the
ORF content of E. coli suggests a proteome size distribution peak
at approximately 20 kDa (Figure 2 A and B). One possible reason
for the size difference observed is the presence of a large number of
homo- and hetero-oliogomers in the E. coli proteome. Studies of E.
coli proteins and protein complexes demonstrated similar results,
with the majority of proteins existing in complexes of varying
stability [20]. In addition, all proteins crystallized were oligomeric.
Oligomer formation has been postulated to increase the stability of
a given protein species [22]. This likely selects for proteins that are
highly stable and potentially more crystallizable [23].
Intracellular protein quantification studies of E. coli have shown
that essential proteins are present with at least ten copies per cell
and are present in higher concentrations than many non-essential
proteins under steady state growth conditions [24]. We expected
to see an over representation of high abundance and/or essential
proteins in our crystallization experiments. Single cell protein
concentration data were available for 14 of the 23 structures
solved, and of these, only inorganic pyrophosphatase is an essential
protein in E. coli. Nine of the non-essential proteins were high
abundance (more than 10 copies per cell), while four of the
remaining proteins had copy numbers ranging from 0.152
(pyruvate kinase I) to 2.6 (lysyl-tRNA synthetase) and are
considered low abundance proteins. Thus, the structures deter-
mined did not sample only highly abundant proteins and/or
essential proteins, but also sampled low abundance non-essential
proteins. In addition, proteins involved in stress response such as
methylglyoxal reductase (YghZ) and heat shock protein 31
(HSP31) [25] were crystallized. While these proteins are likely
constitutively present at low levels under optimum growth
conditions, the high cell density present during fermentor growth
may lead to the induction of a stress response even when
controlling for pH and aeration of the fermentor media. These
results suggest a generally applicable method for altering the
proteomic profile of a bacterial culture by manipulating the
growth conditions to favor the production of proteins involved in
Table 2. Data collection and refinement statistics for
methylglyoxal reductase (YghZ).
YghZ
Data collection
Space group P1
Cell dimensions
a, b, c (A ˚) 91.70, 98.06, 98.26
a, b,a ˜ (u) 90.3, 93.0, 106.1
Resolution (A ˚) 98–1.8 (1.87–1.8)
Rsym 0.06(0.56)
I/sI 9.4(1.6)
Completeness (%) 96.2 (93.3)
Redundancy 3.9(3.9)
Refinement
Resolution (A ˚) 94–1.8
No. reflections 277925
Rwork/Rfree 17.1/20.8
No. atoms
Protein 39762
Ligand/ion 9
Water 2644
B-factors
Protein 28.0
Ligand/ion 20.0
Water 40.2
R.m.s. deviations
Bond lengths (A ˚) 0.019
Bond angles (u) 1.534
*Values in parentheses are for highest-resolution shell.
doi:10.1371/journal.pone.0032498.t002
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concentration of specific proteins, the likelihood of their
subsequent purification and crystallization can be increased.
A non-trivial issue was the identification of the proteins upon
successful crystallization. The small quantities of available sample
coupled with the relative complexity of the fractions made protein
identification by mass spectrometry difficult. Studies using samples
obtained from capillary gel electrophoresis couple with time of
flight mass spectrometry have been shown to give good results with
picogram quantities of material [26,27]. It is likely that
optimization of the mass spectrometric parameters and the use
of equipment devoted to the identification of small amount of
protein samples purified via capillary gel electrophoresis would
greatly improve the success rate of mass spectrometry for routine
protein identification. For this study, brute force molecular
replacement provided a more robust method for the routine
identification of crystallized protein samples, with a success rate of
,80% for well diffracting (better than 3.5 A ˚) crystals.
Brute force molecular replacement (MR) was used to both
identify the crystallized proteins and address the fundamental
problem of phasing the crystallographic data. Native data does not
allow the ab initio structure determination and either MR search
models, heavy atom derivatives, or, in more limited cases, changes
due to radiation damage, are needed to successful phase a
structure. In the case of inorganic pyrophosphatase, for example,
the crystals were isomorphous to published structures in the
Protein Data Bank (PDB) and hence a strong candidate was
identified based on the cell constants and symmetry information
alone. For the majority of the crystal structures, cell constants were
not sufficient to identify the protein, leading to the use of brute
force MR trials. The relatively simple MR protocol used in this
study was designed to run on limited computational resources
(typically 1 week on a single-processor system), which reduces the
search space and sensitivity. Recent advances in the application of
structure prediction methods [28,29,30,31] and assembly of helical
fragments [32] have expanded the range of structures accessible by
MR to the point where it resembles true ab initio phasing, at the
cost of massive computational overhead [33]. However, the
ongoing evolution of multiprocessor systems, and the availability of
massively parallel computing ‘‘grids’’ [34], will make these
technologies more accessible to the average laboratory.
The twenty-three structures determined here represent a
significant fraction of the 767 unique structures deposited in the
PDB for E. coli, one of the most structurally studied model
organisms. Because the PDB contains over 75,000 structures and
an increasing amount of ‘‘fold space’’ is being sampled due in large
part to the efforts of the structural genomics consortia [35], brute
force molecular replacement is fast becoming an increasingly
viable method for structure solution [34,36,37]. However, MR
was not sufficient to determine six structures for which we
collected native data of resolution better than 3.5 A ˚. Although our
sample size is small, our 40% success rate (4 solved/10 collected of
resolution better than 3.5 A ˚) with novel structures using MR
suggests that significantly more structures would need to be solved
to completely access the meta-proteome using MR strategies
alone.
In addition to MR, attempts were made at heavy atom
derivatization using mercury, NaBr and NaI soaks as well as
phasing using the sulphur edge. While these approaches were
successful on test crystals, we were not able to obtain useful phase
information for the remaining unsolved data sets. Heavy atom
derivatization often requires extensive optimization of soaking
conditions through trial and error and thus a large number of
crystals. As we were limited in the number of crystals available and
the amount of sample for crystal optimization, this approach was
not successful. Generally our crystals were small and suffered from
radiation damage after collection of a complete dataset. The
highly redundant data necessary for sulphur SAD phasing was not
obtainable for the unsolved data sets. However, optimization of
data collection parameters such as wavelength and exposure times
would likely improve the success rate of sulphur SAD. Radiation
induced phasing (RIP) [38,39] was not attempted in the current
Figure 5. YghZ tetramer and active site. Left, the YghZ tetramer viewed along the four-fold axis. Putative active site residues are depicted as
ball-and-stick and colored by atom with the active site of one monomer outlined by a gray box. Right, close -up view of the active site with putative
active site residues colored by atom and labeled.
doi:10.1371/journal.pone.0032498.g005
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phase problem. For bacterial targets such as E. coli, selenomethi-
onine incorporation provides an alternative to traditional heavy
atom derivitization and works routinely for recombinantly
expressed proteins. A drawback to this approach is the toxicity
and cost of selenomethionine. An estimated 500 g of E. coli grown
in a 120 L fermentor would require at least twelve grams of L-
selenomethionine, a substantial cost and disposal issue. However,
for some bacterial targets this may provide an attractive alternative
to relying on MR solutions or heavy atom soaking.
These studies comprise a first attempt to explore the feasibility
and potential of using a macro-to-micro approach to fractionate
and purify proteins exclusively from a native source for high-
throughput crystallization and structure determination. As the
scope of this pilot study is relatively small, the aim was to test an
initial production pipeline using the model organism, E. coli. The
success and efficacy of our native-source purification and
crystallization were assessed by comparing the number of datasets
collected compared with the number of available structures in the
PDB and also the number of unknown protein structures identified
and solved using native-source purification. The general utility of
this approach is not limited to bacteria, but can be easily adapted
to structurally study the proteomes of higher organisms or
proteomes of specific tissues during different developmental stages,
provided that a sufficient starting pool of protein is available for
fractionation, purification, and crystallization. Not only is the
pipeline presented here applicable to different source organisms or
specific tissue types, but it is also feasible on a single lab scale. The
combination of native source protein purification with novel
microfluidic technology enables crystallographic characterization
of protein samples orders of magnitude smaller than traditional
crystallographic methodologies would suggest. These results
validate the ‘‘macro-to-micro’’ approach as a complementary
method to recombinant methodologies currently employed by
structural genomics initiatives.
Methods
Preparation of Soluble Protein Extracts from E. coli
A 4 L culture of E. coli DH5a cells grown overnight in minimal
media by shaking at 37uC was used to inoculate a 120 L fermentor
containing minimal media. The cells were grown to log phase,
harvested by continuous-flow centrifugation, washed, and frozen
in liquid nitrogen. The 1 kg cell pellet was resuspended in 3 L of
lysis buffer (10 mM NaCl, 25 mM Tris pH 7.0, 1 mM DTT and
0.05% Triton X-100) and lysed by two passages through an
EmulsiFlex-C3 homogenizer at 10,000 psi. The cell debris was
removed by centrifugation for 60 min at 15,000 rpm. A Bradford
protein assay was used to determine the protein concentration
Table 3. Data collection and refinement statistics for Glucose-
6-phosphate isomerase (pGI).
pGI
Data collection
Space group P1
Cell dimensions
a, b, c (A ˚) 69.8, 72.9, 181.9
a, b,a ˜ (u) 92.5, 97.8, 114.6
Resolution (A ˚) 179.–2.05 (2.1–2.05)
Rsym 0.097(0.34)
I/sI 7.3 (1.2)
Completeness (%) 95.0 (95.0)
Redundancy 2.0(2.1)
Refinement
Resolution (A ˚) 89–2.05
No. reflections 186581
Rwork/Rfree 17.2/23.0
No. atoms
Protein 25984
Ligand/ion 1
Water 3262
B-factors
Protein 23.1
Ligand/ion 27.5
Water 30.3
R.m.s. deviations
Bond lengths (A ˚) 0.011
Bond angles (u) 1.300
*Values in parentheses are for highest-resolution shell.
doi:10.1371/journal.pone.0032498.t003
Figure 6. PGI dimer and putative active site. Left, the pGI dimer. Right, close -up view of the active site with putative active site residues colored
by atom and labeled. The active site is formed at the dimer interface and has contributions from both monomers.
doi:10.1371/journal.pone.0032498.g006
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protease inhibitors and the nucleic acids were digested using
DNaseI.
Whole-proteome fractionation pipeline
Tangential flow filtration (TFF) using the ProFlux M12
(Millipore) with a nominal molecular weight cutoff (NMWC) of
.500,000 Da was used to remove cell debris, aggregates, and
large complexes from the lysate. The retentate was purified using a
sequence of three purification steps: sucrose gradientRTSK-Gel
G4000SWRion exchange chromatography on an 8 ml MonoQ
column (GE Healthcare Life Sciences). The permeate, at
,500,000 Da, was subjected to a sequence of three or more
orthogonal purification steps (affinity interactions, multiple ion
exchangers, hydrophobic interaction and/or size exclusion). In a
standard protocol, 50 to 500 ml of the permeate was applied to
different capture resins, with column volume and permeate
volume scaled according to the capacity of the capture resin.
The initial separation step was performed on one of the five
choices of resins. The capture columns used were CaptoQ
columns (quaternary ammonium, anion exchanger resin), Capto
MMC (multimodal weak cation exchanger resin), Blue Sepharose
columns (triazine coupling resin), Heparin Sepharose columns
(reductive amination resin) or on SP Sepharose columns
(Sulfopropyl strong cation resin). The columns were eluted in 3
to 5 steps, and each subsequent step was then applied to a Phenyl
sepharose column and further subdivided into 6 fractions. These
fractions were then applied to a preparatory scale Superdex 200
column (GE Healthcare Life Sciences) or a polishing high
resolution ionic exchange 8 ml MonoQ or MonoS column
(polystyrene/divinyl benzene particles substituted with quaternary
amino (Q) or methyl sulfonate groups (S). The eluted fractions
were 1 ml in volume and collected in 96 well trays. For example,
YghZ was purified via heparin sepharose, phenyl sepharose, and
then a polishing MonoQ step. BglA, GDH, and pGI were purified
in a similar manner as YghZ, with the exception of the initial
heparin column being replaced by a CaptoQ step.
The purity of the fractions was assessed by 1-D electrophoretic
separation with the LabChip90 Caliper LifeSciences System.
Similar fractions were pooled and concentrated using spin
concentrators to 10–20 mg/ml for crystallization. Mass spectrom-
etry was used for the identification of the fraction of samples that
crystallized.
Mass spectrometry
Mass spectrometry and tandem mass spectrometry (MS/MS)
were performed using a quadrupole time-of-flight mass spectrom-
Table 4. Data collection and refinement statistics for 6-
phospho-beta-glucosidase (BglA).
BglA
Data collection
Space group P1
Cell dimensions
a, b, c (A ˚) 73.7, 79.4, 98.6
a, b,a ˜ (u) 100.0, 107.2, 102.8
Resolution (A ˚) 22.9–2.3 (2.42–2.3)
Rsym 0.143(0.53)
I/sI 7.9 (2.2)
Completeness (%) 92.7 (66.3)
Redundancy 4.0(3.9)
Refinement
Resolution (A ˚) 22.9–2.3
No. reflections 82815
Rwork/Rfree 23.7/17.1
No. atoms
Protein 16976
Ligand/ion 19
Water 1651
B-factors
Protein 20.0
Ligand/ion 72.5
Water 23.78
R.m.s. deviations
Bond lengths (A ˚) 0.003
Bond angles (u) 0.704
*Values in parentheses are for highest-resolution shell.
doi:10.1371/journal.pone.0032498.t004
Figure 7. BglA dimer and putative active site. Left, BglA dimer with the putative active site outlined in a gray box. Right, close up of the active
site with glucose-6-phosphate modeled based of the position of the sulfate ion from crystallization. Active site residues are depicted as ball-and-stick.
Putative hydrogen bonds to the substrate are drawn as dashed lines.
doi:10.1371/journal.pone.0032498.g007
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a nanoelectrospray ionization source and connected in-line with
an ultraperformance liquid chromatograph (nanoAcquity UPLC,
Waters). ESI mass spectra of intact proteins were processed using
MassLynx software (version 4.1, Waters). The data resulting from
UPLC-MS/MS analysis of trypsin-digested proteins were searched
against the Swiss-Prot database using ProteinLynx Global Server
software (Waters). Protein identifications were validated by
manual inspection of the MS/MS spectra.
Crystallization
All the fractions were screened in Topaz
TM 8.96 (Fluidigm
Corporation) microfluidic crystallization chips against Index and
OptiMix screens at room temperature, using approximately 1 mL
of protein sample per 96-well screen. The results were viewed and
analyzed by the AutoInspexH station, which records images of
each experiment over a 7 day period and automatically scores
each experiment. Samples yielding high-quality crystals were
reproduced and optimized in Greiner 96 well sitting drop plates
using the MosquitoH crystallization robot (TTP Labtech).
Depending on amount of sample available, optimization condi-
tions were chosen to sample a range of precipitant conditions,
generally +/220% from the initial crystal hit. Lower quality
crystals were improved by screening crystallization additives or
further sample purification. For small sample volume and in cases
where crystals from the initial screen were not reproduced by
vapor diffusion, diffraction-capable microfluidic chips (Fluidigm
Corp.) were screened for diffraction.
Data Collection
Crystals grown in conventional trays were cryoprotected prior
to flash freezing in liquid nitrogen by transferring to a solution
containing either a higher (.30%) concentration of precipitant
where possible (PEG 1000, 3500-based conditions) or 50%
glycerol. Crystals grown in diffraction-capable chips were
cryoprotected by cutting open liquid channels and allowing a
50% glycerol solution to diffuse into the crystallization chamber.
Sections of the chips containing crystals were then excised and
attached to magnetic mounting pins before freezing. Data were
collected at ALS beamlines 8.3.1, 12.3.1, and 8.2.1, and SSRL
beamlines 9-1 and 9-2, and processed with HKL2000 [40],XDS
[41], or MOSFLM [42] and SCALA [43], using the Elves
automation software [44]. All data sets were obtained from a
single crystal except for the in-chip crystals of 5-keto-4-
deoxyuronate.
Table 5. Data collection and refinement statistics for
glutamate dehydrogenase (GDH).
GDH
Data collection
Space group P212121
Cell dimensions
a, b, c (A ˚) 101.9 151.6 170.0
a, b,a ˜ (u) 90.0 90.0 90.0
Resolution (A ˚) 40.0–3.2 (3.32–3.20)
Rsym 0.164 (0.515)
I/sI 7.9 (2.3)
Completeness (%) 99.8 (99.7)
Redundancy 3.7 (3.6)
Refinement
Resolution (A ˚)3 8 – 3 . 2
No. reflections 43835
Rwork/Rfree 0.2286/0.2653
No. atoms
Protein 19913
Ligand/ion 8
Water 44
B-factors
Protein 64.6
Ligand/ion 48.3
Water 29.5
R.m.s. deviations
Bond lengths (A ˚) 0.001
Bond angles (u) 0.424
doi:10.1371/journal.pone.0032498.t005
Figure 8. GDH hexamer from E. coli. The protein forms a hexamer (dimer of trimers). Left, view of the GDH hexamer along the two-fold axis. Right,
view of the GDH hexamer along the three-fold axis.
doi:10.1371/journal.pone.0032498.g008
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The space group and unit cell dimensions of each crystal were
used to search the E. coli proteins in the PDB for candidate
molecules. Mass spectrometry was used to determine the identity
of unknown crystallized proteins, where possible. In all other cases,
brute-force molecular replacement (MR) trials were conducted
using all structures in the PDB with at least 30% sequence identity
to an Escherichia coli ORF. At the time of these experiments, there
were approximately 10,000 unique structures with at least 30%
sequence identity to an E. coli open reading frame. Decreasing the
percent sequence identity to 25% yielded approximately 15,000
structures, however, no further MR solutions were found for the
datasets. The program MOLREP [8] was used to calculate scores
for the rotation function alone, the highest scoring functions were
selected, and the candidate structures were subjected to full MR
using MOLREP or PHASER [9]. In the case of YghZ, MR alone
could not distinguish between several homologous ORFs, and the
model was partially refined and rebuilt with ARP/wARP [45–
46]to an R-free of 37%, at which point the high resolution of the
data allowed identification of unique sequences in the electron
density.
Structures for proteins already deposited in the PDB were not
refined except to confirm the molecular replacement solutions. For
the novel structures, initial models were refined using either
REFMAC [43,47] or phenix.refine [48,49], and rebuilt using
ARP/wARP or phenix.autobuild [50] where the resolution was
high enough. The rebuilt models were then iteratively refined with
manual building in Coot [51] and refinement with phenix.refine
or REFMAC. NCS restraints were applied throughout refinement
until the final stages, where they were released if resolution was
2.1 A ˚ or better. PyMOL [52] was used to generate all structure
figures. Novel structures are deposited in the PDB under codes
3N6Q, 2XHY, 3NBU, 3SBO for YghZ, BglA, pGI, and GDH,
respectively. Ramachandran statistics for YghZ were 97%
(favored), 2.6% (allowed), 0.4% (disallowed), for BglA 97.1%
(favored), 2.8% (allowed), 0.1% (disallowed), for pGI 96%
(favored), 3.8% (allowed), 0.3% (disallowed), and for GDH
86.1% (favored), 13.5% (allowed), 0.4% (disallowed).
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